- Home
- MET vs EW Comparison
MET vs EW Comparison
Compare MET & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MET | EW |
|---|---|---|
| Founded | 1863 | 1958 |
| Country | United States | United States |
| Employees | 46000 | N/A |
| Industry | Life Insurance | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.4B | 49.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | MET | EW |
|---|---|---|
| Price | $93.96 | $86.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | $93.93 | ★ $96.37 |
| AVG Volume (30 Days) | 3.3M | ★ 3.9M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $4.40 | $13.39 |
| Revenue Next Year | $4.51 | $9.81 |
| P/E Ratio | ★ $16.82 | $133.58 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $67.33 | $72.30 |
| 52 Week High | $94.09 | $96.29 |
Technical Indicators
Market Signals| Indicator | MET | EW |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 40.64 |
| Support Level | $74.63 | $82.02 |
| Resistance Level | N/A | $86.49 |
| Average True Range (ATR) | 1.76 | 2.27 |
| MACD | 0.29 | -0.91 |
| Stochastic Oscillator | 91.91 | 7.28 |
Price Performance
Historical ComparisonAbout MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.